Literature DB >> 15918021

The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy.

H Skovbjerg, L Tarnow, H Locht, H-H Parving.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15918021     DOI: 10.1007/s00125-005-1776-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG.

Authors:  E Fabiani; C Catassi
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 2.566

2.  High prevalence of coeliac disease in Danish children with type I diabetes mellitus.

Authors:  D Hansen; F N Bennedbaek; L K Hansen; M Høier-Madsen; L S Hegedü; B B Jacobsen; S Husby
Journal:  Acta Paediatr       Date:  2001-11       Impact factor: 2.299

Review 3.  Coeliac disease and Type 1 diabetes mellitus - the case for screening.

Authors:  G K Holmes
Journal:  Diabet Med       Date:  2001-03       Impact factor: 4.359

Review 4.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.

Authors:  L M Sollid; E Thorsby
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

5.  Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.

Authors:  M Lajer; L Tarnow; J Fleckner; B V Hansen; D G Edwards; H-H Parving; E Boel
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

6.  Low birth weight. A risk factor for development of diabetic nephropathy?

Authors:  P Rossing; L Tarnow; F S Nielsen; B V Hansen; B M Brenner; H H Parving
Journal:  Diabetes       Date:  1995-12       Impact factor: 9.461

7.  A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease.

Authors:  Rakesh Amin; Nuala Murphy; Julie Edge; Marion L Ahmed; Carlo L Acerini; David B Dunger
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

  7 in total
  6 in total

Review 1.  Screening for celiac disease in the general population and in high-risk groups.

Authors:  Jonas F Ludvigsson; Timothy R Card; Katri Kaukinen; Julio Bai; Fabiana Zingone; David S Sanders; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

2.  Selective immunoglobulin a deficiency in type 1 diabetes mellitus: a prevalence study in Western sicily (Italy).

Authors:  Domenico Greco; Filippo Maggio
Journal:  Diabetes Metab J       Date:  2015-03-10       Impact factor: 5.376

3.  Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.

Authors:  Katherine V Williams; Christina L Cristaldi; Rachel G Miller; Vincent C Arena; Ingrid Libman; Yihe Huang; Dorothy J Becker; Trevor J Orchard
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

4.  Risk of renal disease in patients with both type 1 diabetes and coeliac disease.

Authors:  Kaziwe Mollazadegan; Michael Fored; Sigrid Lundberg; Johnny Ludvigsson; Anders Ekbom; Scott M Montgomery; Jonas F Ludvigsson
Journal:  Diabetologia       Date:  2014-03-25       Impact factor: 10.122

5.  High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease.

Authors:  John S Leeds; Andrew D Hopper; Marios Hadjivassiliou; Solomon Tesfaye; David S Sanders
Journal:  Diabetes Care       Date:  2011-09-12       Impact factor: 19.112

Review 6.  Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy.

Authors:  Sjoerd F Bakker; Maarten E Tushuizen; Boudewina M E von Blomberg; Hetty J Bontkes; Chris J Mulder; Suat Simsek
Journal:  Diabetol Metab Syndr       Date:  2016-07-29       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.